In this Book

summary

In Prescription for the People, Fran Quigley diagnoses our inability to get medicines to the people who need them and then prescribes the cure. He delivers a clear and convincing argument for a complete shift in the global and U.S. approach to developing and providing essential medicines—and a primer on how to make that change happen.

Globally, 10 million people die each year because they are unable to pay for medicines that would save them. The cost of prescription drugs is bankrupting families and putting a strain on state and federal budgets. Patients’ desperate need for affordable medicines clashes with the core business model of the powerful pharmaceutical industry, which maximizes profits whenever possible. It doesn’t have to be this way. Patients and activists are aiming to make all essential medicines affordable by reclaiming medicines as a public good and a human right, instead of a profit-making commodity. In this book, Quigley demystifies statistics and terminology, offers solutions to the problems that block universal access to medicines, and provides a road map for activists wanting to make those solutions a reality.

Table of Contents

  1. Cover
  2. restricted access Download |
  1. Half Title, Series Info, Title Page, Copyright
  2. restricted access Download |
  1. Contents
  2. pp. vii-x
  3. restricted access Download |
  1. Acknowledgments
  2. pp. xi-xvi
  3. restricted access Download |
  1. Introduction
  2. pp. 1-4
  3. restricted access Download |
  1. Part I. Toxic Impacts
  1. 1. People Everywhere Are Struggling to Get the Medicines They Need
  2. pp. 7-12
  3. restricted access Download |
  1. 2. The United States Has a Drug Problem
  2. pp. 13-18
  3. restricted access Download |
  1. 3. Millions of People Are Dying Needlessly
  2. pp. 19-24
  3. restricted access Download |
  1. 4. Cancer Patients Face Particularly Deadly Barriers to Medicines
  2. pp. 25-30
  3. restricted access Download |
  1. 5. The Current Medicine System Neglects Many Major Diseases
  2. pp. 31-34
  3. restricted access Download |
  1. Part II. Profits over Patients
  1. 6. Corporate Research and Development Investments Are Exaggerated
  2. pp. 37-42
  3. restricted access Download |
  1. 7. The Current System Wastes Billions on Drug Marketing
  2. pp. 43-46
  3. restricted access Download |
  1. 8. The Current System Compromises Physician Integrity and Leads to Unethical Corporate Behavior
  2. pp. 47-56
  3. restricted access Download |
  1. 9. Medicines Are Priced at Whatever the Market Will Bear
  2. pp. 57-64
  3. restricted access Download |
  1. 10. Pharmaceutical Corporations Reap History-Making Profits
  2. pp. 65-68
  3. restricted access Download |
  1. Part III. Patently Poisonous
  1. 11. The For-Profit Medicine Arguments Are Patently False
  2. pp. 71-74
  3. restricted access Download |
  1. 12. Medicine Patents Are Extended Too Far and Too Wide
  2. pp. 75-82
  3. restricted access Download |
  1. 13. Patent Protectionism Stunts the Development of New Medicines
  2. pp. 83-86
  3. restricted access Download |
  1. 14. Governments, Not Private Corporations, Drive Medicine Innovation
  2. pp. 87-90
  3. restricted access Download |
  1. 15. Taxpayers and Patients Pay Twice for Patented Medicines
  2. pp. 91-94
  3. restricted access Download |
  1. Part IV. Trading Away Our Health
  1. 16. Medicines Are a Public Good
  2. pp. 97-102
  3. restricted access Download |
  1. 17. Medicine Patents Are Artificial, Recent, and Government-Created
  2. pp. 103-108
  3. restricted access Download |
  1. 18. The United States and Big Pharma Play the Bully in Extending Patents
  2. pp. 109-118
  3. restricted access Download |
  1. 19. Pharma-Pushed Trade Agreements Steal the Power of Democratically Elected Governments
  2. pp. 119-124
  3. restricted access Download |
  1. Part V. A Better Remedy
  1. 20. Current Law Provides Opportunities for Affordable Generic Medicines
  2. pp. 127-136
  3. restricted access Download |
  1. 21. There Is a Better Way to Develop Medicines
  2. pp. 137-146
  3. restricted access Download |
  1. 22. Human Rights Law Demands Access to Essential Medicines
  2. pp. 147-152
  3. restricted access Download |
  1. Conclusion
  2. pp. 153-172
  3. restricted access Download |
  1. Notes
  2. pp. 173-236
  3. restricted access Download |
  1. Index
  2. pp. 237-243
  3. restricted access Download |

Additional Information

ISBN
9781501713910
Related ISBN
9781501713927
MARC Record
OCLC
1017610502
Pages
260
Launched on MUSE
2018-01-03
Language
English
Open Access
No
Back To Top

This website uses cookies to ensure you get the best experience on our website. Without cookies your experience may not be seamless.